Body mass index, waist circumference, diabetes, and risk of liver cancer for U.S. adults

Cancer Research

Volumn 76, Issue 20, 2016, Pages 6076-6083

  Campbell, Peter T ^a   Newton, Christina C ^a   Freedman, Neal D ^b   Koshiol, Jill ^b   Alavanja, Michael C ^b   Freeman, Laura E Beane ^b   Buring, Julie E ^c,d   Chan, Andrew T ^c,e   Chong, Dawn Q ^e,f   Datta, Mridul ^g   Gaudet, Mia M ^a   Gaziano, J Michael ^c,h   Giovannucci, Edward L ^d   Graubard, Barry I ^b   Hollenbeck, Albert R ⁱ   King, Lindsey ^c,e   Lee, I Min ^c,d   Linet, Martha S ^b   Palmer, Julie R ^j   Petrick, Jessica L ^b   Poynter, Jenny N ^k   Purdue, Mark P ^b   Robien, Kim ^l   Rosenberg, Lynn ^j   Sahasrabuddhe, Vikrant V ^b   Schairer, Catherine ^b   Sesso, Howard D ^c,d   Sigurdson, Alice J ^b   Stevens, Victoria L ^a   Wactawski Wende, Jean ^m   Zeleniuch Jacquotte, Anne ⁿ   Renehan, Andrew G ^o   McGlynn, Katherine A ^b   more..

^a AMERICAN CANCER SOCIETY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^g PURDUE UNIVERSITY   (United States)

^h Boston VA Healthcare System   (United States)

ⁱ AARP   (United States)

^j BOSTON UNIVERSITY   (United States)

^k UNIVERSITY OF MINNESOTA   (United States)

^l GEORGE WASHINGTON UNIVERSITY   (United States)

^m UNIVERSITY AT BUFFALO   (United States)

ⁿ NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^o UNIVERSITY OF MANCHESTER   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL;

ADULT; AGE; ARTICLE; BILE DUCT CARCINOMA; BODY MASS; CANCER RISK; CONTROLLED STUDY; FEMALE; HUMAN; LIVER CANCER; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RACE; SEX; SEX DIFFERENCE; SMOKING; UNITED STATES; VIRUS HEPATITIS; WAIST CIRCUMFERENCE; AGED; COMPLICATION; LIVER NEOPLASMS; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; WAIST CIRCUMFERENCE;

EID: 84991759835     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-16-0787     Document Type: Article

References (37)

1. Venook AP, Papandreou C, Furuse J, de Guevara LL. The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist 2010;15Suppl 4:5-13.
2. McGlynn KA, Petrick JL, London WT. Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability. Clin Liver Dis 2015;19:223-38.
3. American Cancer Society. Global Cancer Facts and Figures, 2nd Edition. Atlanta, GA: American Cancer Society; 2011.
4. Chang MH, You SL, Chen CJ, Liu CJ, Lee CM, Lin SM, et al. Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. J Natl Cancer Inst 2009;101:1348-55.
5. Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 2009;27:1485-91.
6. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of bodymass index amongUS adults, 1999-2010. JAMA 2012;307:491-7.
7. Geiss LS, Wang J, Cheng YJ, Thompson TJ, Barker L, Li Y, et al. Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980-2012. JAMA 2014;312:1218-26.
8. Wang C, Wang X, Gong G, Ben Q, Qiu W, Chen Y, et al. Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies. Int J Cancer 2012;130: 1639-48.
9. Tanaka K, Tsuji I, Tamakoshi A, Matsuo K, Ito H, Wakai K, et al. Obesity and liver cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol 2012; 42:212-21.
10. Chen Y, Wang X, Wang J, Yan Z, Luo J. Excess body weight and the risk of primary liver cancer: an updated meta-analysis of prospective studies. Eur J Cancer 2012;48:2137-45.
11. Ioannou GN, Splan MF, Weiss NS, McDonald GB, Beretta L, Lee SP. Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol 2007;5:938-45.
12. Chiang CH, Lee LT, Hung SH, Lin WY, Hung HF, Yang WS, et al. Opposite association between diabetes, dyslipidemia, and hepatocellular carcinoma mortality in the middle-aged and elderly. Hepatology 2014;59:2207-15.
13. Chen CL, Yang HI, Yang WS, Liu CJ, Chen PJ, You SL, et al. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology 2008;135:111-21.
14. Schlesinger S, Aleksandrova K, Pischon T, Fedirko V, Jenab M, Trepo E, et al. Abdominal obesity, weight gain during adulthood and risk of liver and biliary tract cancer in a European cohort. Int J Cancer 2013;132: 645-57.
15. White DL, Kanwal F, El-Serag HB. Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review. Clin Gastroenterol Hepatol 2012;10:1342-59.
16. Campbell PT, Newton CC, Patel AV, Jacobs EJ, Gapstur SM. Diabetes and cause-specific mortality in a prospective cohort of one million U.S. adults. Diabetes Care 2012;35:1835-44.
17. Atchison EA, Gridley G, Carreon JD, Leitzmann MF, McGlynn KA. Risk of cancer in a large cohort of U.S. veterans with diabetes. Int J Cancer 2011;128:635-43.
18. Schlesinger S, Aleksandrova K, Pischon T, Jenab M, Fedirko V, Trepo E, et al. Diabetes mellitus, insulin treatment, diabetes duration, and risk of biliary tract cancer and hepatocellular carcinoma in a European cohort. Ann Oncol 2013;24:2449-55.
19. Lai GY, Park Y, Hartge P, Hollenbeck AR, Freedman ND. The association between self-reported diabetes and cancer incidence in the NIHAARP Diet and Health Study. J Clin Endocrinol Metab 2013;98: E497-502.
20. Yang WS, Shu XO, Gao J, LiHL, Cai H, Yang G, et al. Prospective evaluation of type 2 diabetes mellitus on the risk of primary liver cancer in Chinese men and women. Ann Oncol 2013;24:1679-85.
21. Yang WS, Va P, Bray F, Gao S, Gao J, Li HL, et al. The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies. PLoS One 2011;6: e27326.
22. Johnson JA, Carstensen B, Witte D, Bowker SL, Lipscombe L, Renehan AG. Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence. Diabetologia 2012;55: 1607-18.
23. World Health Organization. International Classification for Diseases. 9th ed. Geneva, Switzerland: World Health Organization; 1985.
24. World Health Organization. Report of a WHO consultation on obesity. Obesity: preventing and managing the global epidemic. Geneva, Switzerland: WHO; 1998.
25. Campbell PT, Deka A, Jacobs EJ, Newton CC, Hildebrand JS, McCullough ML, et al. Prospective study reveals associations between colorectal cancer and type 2 diabetes mellitus or insulin use in men. Gastroenterology 2010;139:1138-46.
26. Margolis KL, Lihong Q, Brzyski R, Bonds DE, Howard BV, Kempainen S, et al. Validity of diabetes self-reports in the Women's Health Initiative: comparison with medication inventories and fasting glucose measurements. Clin Trials 2008;5:240-7.
27. Song X, Pukkala E, Dyba T, Tuomilehto J, Moltchanov V, Mannisto S, et al. Body mass index and cancer incidence: the FINRISK study. Eur J Epidemiol 2014;29:477-87.
28. Wang Y, Wang B, Shen F, Fan J, Cao H. Body mass index and risk of primary liver cancer: a meta-analysis of prospective studies. Oncologist 2012;17: 1461-8.
29. Lo SF, Chang SN, Muo CH, Chen SY, Liao FY, Dee SW, et al. Modest increase in risk of specific types of cancer types in type 2 diabetes mellitus patients. Int J Cancer 2013;132:182-8.
30. Koh WP, Wang R, Jin A, Yu MC, Yuan JM. Diabetes mellitus and risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study. Br J Cancer 2013;108:1182-8.
31. Renehan AG, Zwahlen M, Egger M. Adiposity and cancer risk: new mechanistic insights from epidemiology. Nat Rev Cancer 2015;15:484-98.
32. Karagozian R, Derdak Z, Baffy G. Obesity-associated mechanisms of hepatocarcinogenesis. Metabolism 2014;63:607-17.
33. Shields M, Gorber SC, Tremblay MS. Effects of measurement on obesity and morbidity. Health Rep 2008;19:77-84.
34. McAdams MA, Van Dam RM, Hu FB. Comparison of self-reported and measured BMI as correlates of disease markers in US adults. Obesity 2007;15:188-96.
35. Spencer EA, Appleby PN, Davey GK, Key TJ. Validity of self-reported height and weight in 4808 EPIC-Oxford participants. Public Health Nutr 2002;5:561-5.
36. Rimm EB, Stampfer MJ, Colditz GA, Chute CG, Litin LB, Willett WC. Validity of self-reported waist and hip circumferences inmen and women. Epidemiology 1990;1:466-73.
37. Spencer EA, Roddam AW, Key TJ. Accuracy of self-reported waist and hip measurements in 4492 EPIC-Oxford participants. Public Health Nutr 2004;7:723-7.